Pharma-Biotech Alliance Management--Critical Success Factors

Table of Contents

1. Executive Summary

• 1. Overview
  • 1. Summary of Pharma-Biotech Alliance Management - Critical Success Factors

2. Exchange Rates

• 1. Exchange Rates
  • 1. Currency Exchange Rates

3. Research Scope and Methodology

• 1. Scope and Methodology
  • 1. Research Methodology

4. Introduction and Segmentation

• 1. Introduction
  • 1. Background
  • 2. Segmentation

5. Pharmaceutical Industry Overview

• 1. Overview
  • 1. Overview of the Pharmaceutical Industry
  • 2. Identification of the Challenges Facing Pharmaceutical Companies

6. Biotechnology Industry Overview

• 1. Overview
  • 1. Overview of the Biotechnology Industry
  • 2. Identification of the Challenges Facing Biotechnology Companies

7. Key Challenges in Alliance Management

• 1. Challenges
  • 1. Challenges

8. Key Drivers in Alliance Management

• 1. Drivers
  • 1. Drivers

9. Pharma - Biotech Alliances

• 1. Alliances
  • 1. Introduction
  • 2. Overview and Key Trends
  • 3. Key Pharma-Biotech Alliances
  • 4. Case Study - Novartis

10. Biotech - Biotech Alliances

• 1. Alliances
  • 1. Introduction
  • 2. Overview and Key Trends
  • 3. Key Biotech-Biotech Alliances
  • 4. Case Study - Serono

11. Critical Success Factors

• 1. Success Factors
  • 1. Success Factors

12. Strategic Recommendations for Alliance Management

• 1. Recommendations
  • 1. Recommendations
  • 3. Emerging / Small Biotech Companies
  • 4. Larger Biotech / Biopharmaceutical Companies
  • 5. Large Pharma Companies
  • 6. Summary

13. Frost & Sullivan Awards

• 1. Frost & Sullivan Awards for the European Pharma and Biotech Industry
  • 1. 2006 Frost & Sullivan Awards
  • 2. Entrepreneurial Company Award
  • 3. Technology Innovation Award
  • 4. Competitive Strategy Leadership Award

14. Key Industry Participants

• 1. Industry Participants
  • 1. Major Participants

15. Decision Support Databases

• 1. Biotech
  • 1. Number of Biotech Companies
  • 2. Number of Employees in Biotech Companies
  • 3. EPO Biotech Patent
  • 4. Government R&D Investment in Biotechnology
  • 5. Percent Government Biotech R & D Investment
  • 6. Private Investment in Biotechnology
  • 7. Per cent Private Investment in Biotechnology
• 2. Pharmaceutical R&D
  • 1. Pharmaceutical R&D Expenditure
  • 2. Percent Pharmaceutical R&D Expenditure